AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 89 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -50.0% | 1,850 | -35.1% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 2,850 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 2,850 | +54.1% | 0.00% | – |
| Q1 2019 | $2,000 | -85.7% | 1,850 | -78.3% | 0.00% | – |
| Q4 2018 | $14,000 | -33.3% | 8,540 | +30.6% | 0.00% | – |
| Q3 2018 | $21,000 | +75.0% | 6,540 | +58.0% | 0.00% | – |
| Q2 2018 | $12,000 | 0.0% | 4,140 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | +140.0% | 4,140 | +123.8% | 0.00% | – |
| Q4 2017 | $5,000 | -28.6% | 1,850 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | +600.0% | 1,850 | +640.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 250 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 250 | +21.4% | 0.00% | – |
| Q1 2014 | $0 | – | 206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |